Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Pediatric CNS Tumor Resection
NCT02050243Phase 2Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Feb 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in Pediatric central nervous system tumor, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
5-aminolevulinic acid
03
Conditions
Pediatric central nervous system tumor
Beyond the preview
Go deeper on NCT02050243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02050243.